CILcare is the world’s leading R&D services company specialized in ear disorders. Based in Montpellier, Boston, Paris, and Copenhagen, CILcare supports pharma, medtech, animal health and nutraceutical industries to assess efficacy and safety of drugs, cell & gene therapies, and medical devices, on hearing loss, tinnitus, otitis, and ototoxicity. CILcare’s mission is to make hearing a priority & give hope to the 1.5 billion people worldwide waiting for effective solutions.